INNOVATIVE EYEWEAR INC (LUCY) Fundamental Analysis & Valuation

NASDAQ:LUCY • US45791D2080

Current stock price

1.1 USD
+0.02 (+1.85%)
Last:

This LUCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. LUCY Profitability Analysis

1.1 Basic Checks

  • In the past year LUCY has reported negative net income.
  • In the past year LUCY has reported a negative cash flow from operations.
  • LUCY had negative earnings in each of the past 5 years.
  • In the past 5 years LUCY always reported negative operating cash flow.
LUCY Yearly Net Income VS EBIT VS OCF VS FCFLUCY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • LUCY's Return On Assets of -70.22% is on the low side compared to the rest of the industry. LUCY is outperformed by 75.53% of its industry peers.
  • Looking at the Return On Equity, with a value of -76.56%, LUCY is in line with its industry, outperforming 40.43% of the companies in the same industry.
Industry RankSector Rank
ROA -70.22%
ROE -76.56%
ROIC N/A
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LUCY Yearly ROA, ROE, ROICLUCY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

  • LUCY's Gross Margin of 22.83% is on the low side compared to the rest of the industry. LUCY is outperformed by 79.26% of its industry peers.
  • LUCY's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for LUCY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
LUCY Yearly Profit, Operating, Gross MarginsLUCY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

7

2. LUCY Health Analysis

2.1 Basic Checks

  • LUCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LUCY Yearly Shares OutstandingLUCY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M
LUCY Yearly Total Debt VS Total AssetsLUCY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of -0.48, we must say that LUCY is in the distress zone and has some risk of bankruptcy.
  • LUCY has a Altman-Z score of -0.48. This is comparable to the rest of the industry: LUCY outperforms 42.02% of its industry peers.
  • There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.48
ROIC/WACCN/A
WACC8.95%
LUCY Yearly LT Debt VS Equity VS FCFLUCY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 11.98 indicates that LUCY has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 11.98, LUCY belongs to the top of the industry, outperforming 96.81% of the companies in the same industry.
  • A Quick Ratio of 10.13 indicates that LUCY has no problem at all paying its short term obligations.
  • LUCY's Quick ratio of 10.13 is amongst the best of the industry. LUCY outperforms 96.28% of its industry peers.
Industry RankSector Rank
Current Ratio 11.98
Quick Ratio 10.13
LUCY Yearly Current Assets VS Current LiabilitesLUCY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

3

3. LUCY Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%38.99%

3.2 Future

  • Based on estimates for the next years, LUCY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.61% on average per year.
  • The Revenue is expected to grow by 175.43% on average over the next years. This is a very strong growth
EPS Next Y22.16%
EPS Next 2Y32.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year148.28%
Revenue Next 2Y175.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

LUCY Yearly Revenue VS EstimatesLUCY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
LUCY Yearly EPS VS EstimatesLUCY Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

1

4. LUCY Valuation Analysis

4.1 Price/Earnings Ratio

  • LUCY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LUCY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LUCY Price Earnings VS Forward Price EarningsLUCY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LUCY Per share dataLUCY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LUCY's earnings are expected to grow with 32.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.61%
EPS Next 3YN/A

0

5. LUCY Dividend Analysis

5.1 Amount

  • No dividends for LUCY!.
Industry RankSector Rank
Dividend Yield 0%

LUCY Fundamentals: All Metrics, Ratios and Statistics

INNOVATIVE EYEWEAR INC

NASDAQ:LUCY (4/13/2026, 8:00:01 PM)

1.1

+0.02 (+1.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25
Earnings (Next)N/A
Inst Owners6.22%
Inst Owner Change0%
Ins Owners7.67%
Ins Owner Change-16.59%
Market Cap6.93M
Revenue(TTM)N/A
Net Income(TTM)-7.85M
Analysts82.86
Price Target3.06 (178.18%)
Short Float %1.7%
Short Ratio0.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.97%
Min EPS beat(2)15.97%
Max EPS beat(2)23.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.87%
Min Revenue beat(2)-43.24%
Max Revenue beat(2)-34.5%
Revenue beat(4)0
Avg Revenue beat(4)-41.35%
Min Revenue beat(4)-55.39%
Max Revenue beat(4)-32.28%
Revenue beat(8)1
Avg Revenue beat(8)-18.57%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.9
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)-1.9
EYN/A
EPS(NY)-1.48
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS0.38
BVpS1.63
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.22%
ROE -76.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.83%
FCFM N/A
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.89%
Cap/Sales 5.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.98
Quick Ratio 10.13
Altman-Z -0.48
F-Score3
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)402.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.82%
Cap/Sales(5y)37.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y22.16%
EPS Next 2Y32.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%38.99%
Revenue Next Year148.28%
Revenue Next 2Y175.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.33%
EBIT Next 3Y15.27%
EBIT Next 5YN/A
FCF growth 1Y-29.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.43%
OCF growth 3YN/A
OCF growth 5YN/A

INNOVATIVE EYEWEAR INC / LUCY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INNOVATIVE EYEWEAR INC?

ChartMill assigns a fundamental rating of 3 / 10 to LUCY.


What is the valuation status of INNOVATIVE EYEWEAR INC (LUCY) stock?

ChartMill assigns a valuation rating of 1 / 10 to INNOVATIVE EYEWEAR INC (LUCY). This can be considered as Overvalued.


How profitable is INNOVATIVE EYEWEAR INC (LUCY) stock?

INNOVATIVE EYEWEAR INC (LUCY) has a profitability rating of 0 / 10.


What is the financial health of INNOVATIVE EYEWEAR INC (LUCY) stock?

The financial health rating of INNOVATIVE EYEWEAR INC (LUCY) is 7 / 10.